Eden Research (LON:EDEN) Shares Down 4.7% – Time to Sell?

Shares of Eden Research plc (LON:EDEN) dropped 4.7% during trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). Approximately 291,737 shares traded hands during trading, a decline of 69% from the average daily volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The business has a fifty day moving average price of GBX 3.87 and a 200 day moving average price of GBX 3.95. The company has a debt-to-equity ratio of 1.26, a current ratio of 3.80 and a quick ratio of 2.42. The company has a market capitalization of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92.

Insider Activity at Eden Research

In related news, insider Alexander John Abrey acquired 540,540 shares of the company’s stock in a transaction on Tuesday, January 28th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of the company’s stock in a transaction on Thursday, February 6th. The shares were bought at an average price of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is currently owned by corporate insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.